'Pneumonia vap' presentation slideshows

Acute respiratory distress syndrome with many complication

796 views • 51 slides

Hospital Acquired Pneumonia

Hospital Acquired Pneumonia. Definitions. Community acquired pneumonia (CAP) Infection of the lung parenchyma in a person who is not hospitalized or living in a long-term care facility for ? 2 weeks Hospital-acquired pneumonia (HAP)

637 views • 12 slides

Therapeutic Development for Ventilator Associated Pneumonia

248 views • 6 slides

Ventilator Associated Pneumonia VAP Pipeline Therapeutics Development Review H2 2015

This report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ventilator Associated Pneumonia (VAP) and special features on late-stage and discontinued projects

261 views • 6 slides

Ventilator Associated Pneumonia - Pipeline Review, H1 2015

420 views • 5 slides

Ventilator Associated Pneumonia (VAP) Market – Rising Usage For Hospitals, Research Centers And Clinics To Be A Major

Hospital segment dominates the global market owing rising incidence of pneumonia and need for immediate medical assistance

55 views • 4 slides

Ventilator Associated Pneumonia Market In-Depth Analysis by Types, Applications and Manufacturers till 2025

The Ventilator Associated Pneumonia Market, on the basis of end users, is segmented into hospitals, research centers and clinics. Hospital segment dominates the global market owing rising incidence of pneumonia and need for immediate medical assistance. Ventilator-associated pneumonia (VAP) is a type of pneumonia that happens after endotracheal incubation, featured by the presence of a new or progressive virus. VAP is predicted to occur in quarter of all mechanically ventilated patients along with higher risk of being early in course of hospitalization. Risk for VAP is greatest during the first initial days of mechanical ventilation between the intubation and development of VAP. In the recent years, the accumulated risk of death has decreased and is more recently estimated at a significant percentage.

44 views • 4 slides

DOES THE USE OF CHLORHEXIDINE / TUTORIALOUTLETDOTCOM

62 views • 3 slides

Safer Health Care Now! Initiatives: Central Line Infection and Ventilator Associated Pneumonia

Safer Health Care Now! Initiatives: Central Line Infection and Ventilator Associated Pneumonia

85 views • 1 slides